Actualités 17.04.2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 13.05.2024 Canton of Zug funds institute for blockchain research The canton of Zug is contributing to the costs of setting up an institute for blockchain research. The project of the University of Lucerne and L...
News 17.04.2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 23.10.2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News 10.01.2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 22.12.2023 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
Actualités 17.03.2023 Swiss Biotech Center : des solutions innovantes pour le développement biopharmaceutique Installé au BioArk de Monthey, Swiss Biotech Center est un centre de recherche et de développement de pointe dans le domaine de la biotechnologie...
News 17.03.2023 Swiss Biotech Center: innovative solutions for biopharmaceutical development Located at the BioArk in Monthey, Swiss Biotech Center is a leading research and development center in the field of biotechnology.
News 27.10.2023 UZH researchers develop method for transport of large genes Researchers at the University of Zurich (UZH) have developed a new method for transporting large genes, enabling them to be transferred efficient...
News 18.10.2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
News 24.05.2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
Aktuell 24.05.2024 Geistlich erhält EU-Zertifizierung für Kollagen-Portfolio Geistlich Pharma hat die MDR-Zertifizierung für seine Kollagen-Produktpalette erhalten und erfüllt damit die neuen EU-Vorschriften. Die Produkte ...
News 03.08.2023 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...
Actualités 08.03.2022 Le site technologique de BioArk Monthey s’agrandit Suite à une première extension en 2015, le site technologique spécialisé dans les sciences de la vie, BioArk Monthey, s’agrandit à nouveau et acc...
News 08.03.2022 BioArk Monthey’s technology site expands Following a first expansion in 2015, the technology site specialized in life sciences, BioArk Monthey, grows once more with the addition of a thi...
News 24.05.2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...